Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis

Tuberculosis

Volumn 96, Issue , 2016, Pages 31-36

  Sutherland, Jayne S ^a   Mendy, Joseph ^a   Gindeh, Awa ^a   Walzl, Gerhard ^b   Togun, Toyin ^a   Owolabi, Olumuyiwa ^a   Donkor, Simon ^a   Ota, Martin O ^a   Kon Fat, Elisa Tjon ^c   Ottenhoff, Tom H M ^c   Geluk, Annemieke ^c   Corstjens, Paul L A M ^c  

^a Medical Research Council Unit   (Gambia)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CCL4; IP10; Pleural TB; Pulmonary TB; Tuberculosis; UCP LF

Indexed keywords

BIOLOGICAL MARKER; CCL4 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

AREA UNDER THE CURVE; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

AREA UNDER CURVE; BIOMARKERS; CHEMOKINE CCL4; CHEMOKINE CXCL10; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOLOGIC TESTS; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; PREDICTIVE VALUE OF TESTS; ROC CURVE; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 84954425338     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.10.011     Document Type: Article

References (31)

1. C.J. Roy, and D.K. Milton Airborne transmission of communicable infection - the elusive pathway N Engl J Med 350 2004 1710 1712
2. WHO Global tuberculosis report 2014 2014 Accessed at: http://www.who.int/tb/publications/factsheet-global.pdf?ua=1 [accessed 09.06.15]
3. H.-G. Batz, G.S. Cook, and S.D. Reid Towards lab-free TB diagnostics 2011 WHO-TDR Accessed at: http://www.msfaccess.org/sites/default/files/MSF-assets/TB/Docs/TB-Report-TowardsLabFreeTBDX-2011-ENG.pdf [accessed 09.06.15]
4. D.C. Giang, T.N. Duong, D.T. Ha, H.T. Nhan, M. Wolbers, N.T. Nhu, D. Heemskerk, N.D. Quang, D.T. Phuong, P.T. Hang, T.H. Loc, N.T. Lan, N.H. Dung, J. Farrar, and M. Caws Prospective evaluation of GeneXpert for the diagnosis of HIV-negative pediatric TB cases BMC Infect Dis 15 2015 70
5. Tuberculosis IGRA TB tests policy statement 2011 Accessed at: http://www.who.int/tb/publications/IGRA-factsheet.pdf [accessed 09.06.15]
6. C. Tincati, A.J. Cappione III, and J.E. Snyder-Cappione Distinguishing latent from active Mycobacterium tuberculosis infection using Elispot assays: looking beyond interferon-gamma Cells 1 2012 89 99
7. N.N. Chegou, G.F. Black, M. Kidd, P.D. van Helden, and G. Walzl Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report BMC Pulm Med 9 2009 21
8. J.S. Sutherland, D. Garba, A.E. Fombah, A. Mendy-Gomez, F.S. Mendy, M. Antonio, J. Townend, R.C. Ideh, T. Corrah, and M.O.C. Ota Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion PLoS ONE 7 2012 e30324
9. M.O.C. Ota, J.F. Mendy, S. Donkor, T. Togun, M. Daramy, M.P. Gomez, N.N. Chegou, A.K. Sillah, O. Owolabi, B. Kampmann, G. Walzl, and J.S. Sutherland Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum Eur Respir J 44 2014 254 257
10. ® HIV-1/2 Ag/Ab combo test J Infect Dis 205 2012 528 534
11. D. Eibach, B. Traore, M. Bouchrik, B. Coulibaly, N. Coulibaly, F. Siby, G. Bonnot, A.L. Bienvenu, and S. Picot Evaluation of the malaria rapid diagnostic test VIKIA malaria Ag Pf/Pan™ in endemic and non-endemic settings Malar J 12 2013 188
12. M.J. Broadhurst, J.D. Kelly, A. Miller, A. Semper, D. Bailey, E. Groppelli, A. Simpson, T. Brooks, S. Hula, W. Nyoni, A.B. Sankoh, S. Kanu, A. Jalloh, Q. Ton, N. Sarchet, P. George, M.D. Perkins, B. Wonderly, M. Murray, and N.R. Pollock ReEBOV antigen rapid test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study Lancet 386 2015 867 874
13. P.L. Corstjens, C.J. De Dood, D. Kornelis, E.M. Fat, R.A. Wilson, T.M. Kariuki, R.K. Nyakundi, P.T. Loverde, W.R. Abrams, H.J. Tanke, L. Van Lieshout, A.M. Deelder, and G.J. Van Dam Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels Parasitology 141 2014 1841 1855
14. J.A. Downs, G.J. van Dam, J.M. Changalucha, P.L. Corstjens, R.N. Peck, C.J. de Dood, H. Bang, A. Andreasen, S.E. Kalluvya, L. van Lieshout, W.D. Johnson Jr., and D.W. Fitzgerald Association of Schistosomiasis and HIV infection in Tanzania Am J Trop Med Hyg 87 2012 868 873
15. G.J. van Dam, C.J. de Dood, M. Lewis, A.M. Deelder, L. van Lieshout, H.J. Tanke, L.H. van Rooyen, and P.L. Corstjens A robust dry reagent lateral flow assay for diagnosis of active Schistosomiasis by detection of Schistosoma circulating anodic antigen Exp Parasitol 135 2013 274 282
16. K. Bobosha, E.M. Tjon Kon Fat, S.J. van den Eeden, Y. Bekele, J.J. van der Ploeg-van Schip, C.J. de Dood, K. Dijkman, K.L. Franken, L. Wilson, A. Aseffa, J.S. Spencer, T.H. Ottenhoff, P.L. Corstjens, and A. Geluk Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae PLoS Negl Trop Dis 8 2014 e28458
17. R. Petrucci, N. Abu Amer, R.Q. Gurgel, J.B. Sherchand, L. Doria, C. Lama, P. Ravn, M. Ruhwald, M. Yassin, G. Harper, and L.E. Cuevas Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection Pediatr Infect Dis J 27 2008 1073 1077
18. P.L. Corstjens, C.J. de Dood, J.J. van der Ploeg-van Schip, K.C. Wiesmeijer, T. Riuttamäki, K.E. van Meijgaarden, J.S. Spencer, H.J. Tanke, T.H. Ottenhoff, and A. Geluk Lateral flow assay for simultaneous detection of cellular- and humoral immune responses Clin Biochem 44 2011 1241 1246
19. P.L. Corstjens, E.M. Tjon Kon Fat, C.J. de Dood, J.J. van der Ploeg-van Schip, K.L. Franken, N.N. Chegou, J.S. Sutherland, R. Howe, A. Mihret, D. Kassa, M. van der Vyver, J. Sheehama, F. Simukonda, H. Mayanja-Kizza, T.H. Ottenhoff, G. Walzl, A. Geluk AE-TBC Consortium Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa Clin Biochem 2015 Aug 15 [Epub ahead of print]
20. N. Alsleben, M. Ruhwald, H. Rüssmann, F.M. Marx, U. Wahn, and K. Magdorf Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study Scand J Infect Dis 44 2012 256 262
21. E. Whittaker, A. Gordon, and B. Kampmann Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS ONE 3 2008 e3901
22. M.G. Aabye, M. Ruhwald, G. Praygod, K. Jeremiah, M. Faurholt-Jepsen, D. Faurholt-Jepsen, N. Range, H. Friis, J. Changalucha, A.B. Andersen, and P. Ravn Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients Eur Respir J 36 2010 1488 1490
23. K.E. Driscoll Macrophage inflammatory proteins: biology and role in pulmonary inflammation Exp Lung Res 20 1994 473 490
24. J.J. Saukkonen, B. Bazydlo, M. Thomas, R.M. Strieter, J. Keane, and H. Kornfeld Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth Infect Immun 70 2002 1684 1693
25. S.A. Joosten, K.E. van Meijgaarden, N.D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M.R. Klein, A. Geluk, and T.H. Ottenhoff Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 Proc Natl Acad Sci U S A 104 2007 8029 8034
26. K.G. Phalane, M. Kriel, A.G. Loxton, A. Menezes, K. Stanley, G.D. van der Spuy, G. Walzl, and N.N. Chegou Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis Mediat Inflamm 2013 2013 981984
27. K. Bobosha, L. Wilson, K.E. van Meijgaarden, Y. Bekele, M. Zewdie, J.J. van der Ploeg-van Schip, M. Abebe, J. Hussein, S. Khadge, K.D. Neupane, D.A. Hagge, E.S. Jordanova, A. Aseffa, T.H. Ottenhoff, and A. Geluk T-cell regulation in lepromatous leprosy PLoS Negl Trop Dis 8 2014 e2773
28. P.L. Corstjens, C.J. de Dood, J.W. Priest, H.J. Tanke, S. Handali Cysticercosis Working Group in Peru Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer PLoS Negl Trop Dis 8 2014 e2944
29. S.D. Lawn, K. Dheda, A.D. Kerkhoff, J.G. Peter, S. Dorman, C.C. Boehme, and M.P. Nicol Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies BMC Infect Dis 13 2013 407
30. A. Geluk, K.E. van Meijgaarden, L. Wilson, K. Bobosha, J.J. van der Ploeg-van Schip, S.J. van den Eeden, E. Quinten, K. Dijkman, K.L. Franken, E.M. Haisma, M.C. Haks, C.L. van Hees, and T.H. Ottenhoff Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions J Clin Immunol 34 2014 245 255
31. Y.G. Hur, P. Gorak-Stolinska, A. Ben-Smith, M.K. Lalor, S. Chaguluka, R. Dacombe, T.M. Doherty, T.H. Ottenhoff, H.M. Dockrell, and A.C. Crampin Combination of cytokine responses indicative of latent TB and active TB in Malawian adults PLoS ONE 8 2013 e79742